Photodynamic therapy using methylene blue in lung adenocarcinoma xenograft and hamster cheek pouch induced squamous cell carcinoma. (2016)

Peer-Reviewed Study · Obstoy B; Salaun M; Bohn P; Veresezan L; Sesboué R; Thiberville L · March 15, 2016

Obstoy B et al., 2016-03-15: Nude-mouse study of human lung adenocarcinoma xenografts (NCI-H460) treated with intratumoural 1% methylene blue and 630 nm light: mean tumour volume fell 52% (1568 to 544 mm3) while control tumours grew; a hamster cheek-pouch model showed 85.8% mean volume decrease with 4 of 9 complete responses.

Fourteen xenografts were treated in mice, including seven treated with MB-PDT, producing a 52% mean tumor volume regression (1568mm(3)vs. 544mm(3)) compared to seven control cases in which tumor volume increased (p=0.007; Mann-Whitney test).

Obstoy B et al., 2016-03-15: Nude-mouse study of human lung adenocarcinoma xenografts (NCI-H460) treated with intratumoural 1% methylene blue and 630 nm light: mean tumour volume fell 52% (1568 to 544 mm3) while control tumours grew; a hamster cheek-pouch model showed 85.8% mean volume decrease with 4 of 9 complete responses. C5 Obstoy 2016. Study type: in vivo animal study – 7 subcutaneous NCI-H460 human lung adenocarcinoma xenografts in nude mice plus 9 induced squamous carcinomas in hamster cheek pouch. Country: France (Rouen University Hospital). Dose: methylene blue 1% (w/v) injected intratumourally; 630 nm, 200 J/cm (Diomed PDT 630); volume measured before and 15 days after PDT. Funder: not stated in the record. Conflicts: none declared in the record. Comparator: contralateral tumour with illumination alone or MB alone. THIS IS THE STRONGEST XENOGRAFT DOCUMENT: shrinkage is real but partial (mean 52%), measured at 15 days, with no 'no regrowth' claim. Study type: animal.